MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ccd.27993

Медицинская библиотека · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2018

Myocardial fibrosis predicts adverse outcome after MitraClip implantation.

Velu Juliëtte F, Hirsch Alexander, Boekholdt S M, Koch Karel T, Marije Vis M, Nils Planken R, Piek Jan J, Baan Jan, Bouma Berto J

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

High-risk patients with mitral regurgitation (MR) may be treated by a percutaneous mitral valve repair with the MitraClip, but identification of patients who may benefit remains difficult. We aimed to determine whether myocardial fibrosis predicts outcome in MR patients undergoing MitraClip implantation and is beneficial in clinical decision making.

METHODS

Preprocedural to the MitraClip implantation, myocardial fibrosis was analyzed with cardiovascular magnetic resonance (CMR) through late gadolinium enhancement. The CMR data were core-lab adjudicated measured before the MitraClip implantation. Adverse outcome was defined as New York Heart Association (NYHA) class III or IV after 1 month or death within 1 month after the MitraClip implantation.

RESULTS

In total, 23 patients underwent preprocedural CMR, mean age 80 ± 9 years, 45% male, 64% atrial fibrillation and 73% NYHA class III or IV at baseline. Myocardial fibrosis was present in 55% of the patients with degenerative MR and in 64% of the patients with functional MR. An adverse outcome occurred in 69% of the patients with myocardial fibrosis and in 11% of the patients without myocardial fibrosis (P = 0.01).

CONCLUSIONS

Our hypothesis-generating study showed that the presence of myocardial fibrosis predicts adverse outcome in patients undergoing MitraClip implantation. After confirmation with larger sample size, identification of myocardial fibrosis might contribute to assess prognosis and to clinical decision making.

Для цитирования: Velu Juliëtte F, Hirsch Alexander, Boekholdt S M, Koch Karel T, Marije Vis M, Nils Planken R, Piek Jan J, Baan Jan, Bouma Berto J. Myocardial fibrosis predicts adverse outcome after MitraClip implantation.. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2018. DOI: 10.1002/ccd.27993.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.